Results 171 to 180 of about 174,072,709 (188)
Some of the next articles are maybe not open access.

Association of Soluble Suppression of Tumorigenicity 2 with New-Onset Atrial Fibrillation in Acute Myocardial Infarction

Cardiology, 2022
<b><i>Background:</i></b> The combination of acute myocardial infarction (AMI) and atrial fibrillation (AF) is still a thorny problem in the clinic. At present, there are few reports on the role of soluble suppression of tumorigenicity 2 (sST2) in AF after AMI.
Lei, Chen   +6 more
openaire   +2 more sources

Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis

Coronary Artery Disease, 2020
Background Soluble growth stimulation expressed gene 2 (sST2) is the receptor of interleukin (IL)-33. We hypothesized the IL-33/ST2 pathway may be closely related to the progression of coronary atherosclerotic lesions. Methods We analyzed 262 patients, including 63 with stable ...
Ying, Zhang   +4 more
openaire   +2 more sources

Soluble suppression of tumorigenicity-2 predicts pneumonia in patients with inhalation injury: Results of a pilot study

Burns, 2021
Several mechanisms play a role in the development of pneumonia after inhalation injury. Our aim was to analyze whether higher concentrations of inflammatory markers or of biomarkers of epithelial injury are associated with a higher incidence of pneumonia in patients with inhalation injury.Secondary analysis of a single-center prospective observational ...
Mireia Ruiz-Castilla   +8 more
openaire   +2 more sources

OUTCOMES PREDICTION IN CHRONIC HEART FAILURE USING SOLUBLE SUPPRESSION OF TUMORIGENICITY 2

СИСТЕМНЫЙ АНАЛИЗ И УПРАВЛЕНИЕ В БИОМЕДИЦИНСКИХ СИСТЕМАХ, 2023
Цель. Оценить связь растворимого супрессора туморогенности 2 (sST2) с неблагоприятным течением хронической сердечной недостаточности и построить прогностическую модель исходов при данном синдроме. Материалы и методы. В исследование были включены 120 пациентов со стабильной ХСН (62,5% составляли женщины). Средний возраст в выборке – 66,37±8,47 лет.
openaire   +1 more source

The progress of the soluble suppression of tumorigenicity 2 (sST2) in atrial fibrillation

Journal of Interventional Cardiac Electrophysiology, 2022
Jia-Hui Liu, Qian-Feng Han, De-Gang Mo
openaire   +2 more sources

Plasma Soluble Suppression of Tumorigenicity-2 Level with Colchicine in Coronary Artery Disease

International Journal of Pharmaceutical Quality Assurance
Recently, suppression of tumorigenicity 2 (ST2) of the interleukin 1 receptor family has become an important biomarker in cardiovascular disease, more precisely in coronary artery disease. This review discusses two isoforms of ST2: the membrane-bound ST2L and its soluble form, sST2.
Amr Setouhi   +3 more
openaire   +1 more source

Soluble suppression of tumorigenicity 2 (sST2) in chronic heart failure

Therapy, 2022
Tokmachev R.E. Tokmachev   +2 more
openaire   +1 more source

Soluble suppression of tumorigenicity 2 associated with contrast-induced acute kidney injury in patients with STEMI

International Urology and Nephrology
Contrast-induced acute kidney injury (CI-AKI) is a common complication after percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). Soluble suppression of tumorigenicity 2 (sST2) is associated with AKI. However, the relationship between sST2 and CI-AKI is unclear.
Ziyun, Luo   +5 more
openaire   +2 more sources

Serum Interleukin-33 and Soluble Suppression of Tumorigenicity 2 in Bronchial Asthma

The Indian Journal of Chest Diseases and Allied Sciences, 2022
Jasbinder Kaur   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy